1. LisaLiving
2. jesacoyote77
3. bensynergy
4. nekketsukuniokun
1.jesacoyote77 06/04/2018
Ziopharm Oncology Presents Clinical Data Demonstrating Anti-tumor Immune Response of Controlled IL-12 Platform in Breast Cancer and Glioblastoma at American Society of Clinical Oncology (ASCO) Annual
2.bensynergy 10/02/2017
Phase 1/2 still beat all existing approved SOC options for recurrent GBM!
3.LisaLiving 2 days ago
This one is getting tricky going up or not
4.LisaLiving 10/02/2017
Stuck in a range
5.LisaLiving 01/22/2018
Big boost due to Juno
6.LisaLiving 09/29/2017
Quart was good
7.jesacoyote77 2 days ago
FDA Hold, ouch
8.LisaLiving 03/05/2018
Ziopharm Oncology Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW